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ABSTRACT  
Polycyclic polyprenylated acylphloroglucinols (PPAPs) exhibit a broad range of biological activities, such as 
antidepressant, antibacterial, antiviral and antitumor properties. The content of PPAPs in the producing plants is often 
quite low, and their complex structures make total chemical synthesis difficult and economically impractical. Progresses 
in synthetic biology provide an alternative approach for the production of these valuable compounds. Here we present 
our results on reconstruction of the biosynthetic pathways of PPAP precursors in yeast. Based on our previous works on 
the biosynthesis of PPAPs, genes involved in the formation of benzophenones and xanthones from Hypericum sp. and 
other organisms were expressed in yeast either episomally or by integration into the genome. The production of the 
expected products reached around 0.5 mg/l, which is high enough to be the substrate for enzymes of subsequent 
biosynthetic steps. The yeast strains will be further engineered by introducing various prenyltransferase enzymes to 
reconstruct the full biosynthetic pathways of PPAPs. 
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INTRODUCTION 
Polycyclic polyprenylated acylphloroglucinols 
(PPAPs) are a group of structurally fascinating and 
synthetically challenging plant secondary products, 
which exhibit a broad range of biological activities, 
such as antidepressant, antibacterial, antiviral and 
antitumor properties [Yang, 2018]. The biosynthesis of 
PPAPs involves both the type III polyketide pathway 
and the terpenoid pathway. The acylphloroglucinol 
cores of PPAPs are produced via a characteristic type 
III polyketide biosynthesis process involving the 
condensation of one acyl-CoA and three malonyl-CoAs 
to form a tetraketide intermediate, which in turn 
cyclizes and aromatizes to yield acylphloroglucinols. 
Prenylation of this core structure and further 
cyclization of the prenyl side chains afford different 
PPAPs with diverse carbon skeletons. The type of acyl 
group, the number and position of isoprenyl residues, 
the degree of oxidation of isoprenyl side chains and the 
corresponding locations of ether rings as well as 
different types of secondary cyclizations (such as aldol, 
Diels−Alder, etc.) create PPAPs’ structural diversity 
and complexity.  
PPAPs have been exclusively isolated from plants of 
the families Hypericaceae and Clusiaceae, mainly from 
the genera Hypericum and Garcinia with only few 
exceptions [Fiesel, 2015]. The content of PPAPs in the 
producing plants is often quite low, and their complex 
structure makes total chemical synthesis very difficult 
and in general economically impractical because of the 
low yield. Recent progresses in synthetic biology 
provide an alternative approach for the production of 
these valuable compounds. For example, artemisinic 
acid, the precursor of the antimalarial drug artemisinin, 
was successfully produced in engineered yeast cells 
with a yield of 25 g/l. Here we present our results of 
reconstruction of the biosynthetic pathways of benzo-
phenone and xanthone in yeast. 
RESEARCH CONCEPT 
Plasmid construction and yeast strains:  HpPKS006 
is a type III polyketide synthase gene cloned from 
Hypericum perforatum, which has both benzophenone 
synthase (BPS) and isobutyrophenone synthase (IBS) 
activities [unpublished]. RpBZL is a benzoyl-CoA 
ligase gene from Rhodopseudomonas palustris 
[Egland, 1995]. HcTXS and HcX6H are xanthone 
synthase and xanthone 6-hydroxylase from H. 
calycinum, respectively [El-Awaad, 2016]. HpPT8 is a 
xanthone prenyltransferase [Fiesel, 2015]. Yeast strains 
used are INVSc1 (Invitrogen), CEN.PK102-5B 
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[Entian, 2007] and DD104, which contains down-
regulation of endogenous farnesyl pyrophosphate 
synthase, ERG20, by site-directed mutation of K197G, 
proven to provide more free IPP/DMAPP and GPP 
[Fischer, 2011, Li, 2015]. Genome intergration was 
carried out using integrative EasyClone vectors with 
auxotrophic selection markers [Jensen, 2014].  
Fig. 1 Schematic illustration of the reconstruction of 
PPAP biosynthetic pathways in yeast. The endogenous 
yeast genes are in green, exogenous genes are in red.  
Reconstruction of benzophenone and xanthone 
biosynthetic pathways in yeast: HpPKS006 and 
RpBZL were subcloned into the vector pESC-URA 
(Agilent Technologies), HcTXS and HcCPR 
(cytochrome P450 reductase gene from H. calycinum) 
were subcloned into the vector pESC-LEU. HcX6H 
and HpPT8 were subcloned into the vector pESC-HIS.  
The promoters of all the pESC vectors were changed to 
the constitutive promoter TEF1-PGK1. 
Different combinations of the constructs were co-
transformed into appropriate yeast strains using a high 
efficiency lithium acetate transformation protocol 
[Gietz, 2007]. The resulting positive yeast clones, after 
being verified by PCR, were cultured in 10 ml of 
synthetic dextrose dropout medium (-Leu, -His, -uracil) 
with D-glucose as the carbon source at 30°C and 200 
rpm shaking for 36 hours. Then, the yeast cells were 
diluted into 20 ml of different media to OD600 0.05 and 
cultured at the same conditions. Benzoic acid was 
added at different time points with a final concentration 
of 3.5 mM. One ml of yeast cultures were taken at 
different time points, extracted twice with the same 
volume of ethyl acetate. Extracts were combined and 
dried under a stream of nitrogen, the residues were 
dissolved in 50% (v/v) methanol for HPLC-DAD 
analysis. The product peaks were collected from HPLC 
and analyzed by LC-MS. The content of target 
compounds in the samples was quantified based on 
calibration curves of authentic references. 
RESULTS 
Selection of culture medium: Among the three 
common yeast culture media, YPD is the best for both 
growth and product formation (Table 1). There are no 
significant differences between episomal expression 
and genome integration of the pathway genes.    
Table 1 Kinetics of growth and benzophenone 
production in YPD, YPGE and SGI media 
Medium Strain µmax
(h-1)
OD30h
(rel. AU) 
r 
(µg -1h-1) 
Cmax 
(µg l-1) 
YPD genome 0.389 16.60 12.5 180 
episomal 0.386 13.62 12.8 230 
YPGE genome 0.195 3.24 1.7 60 
episomal 0.190 3.50 1.1 40 
SGI genome 0.290 3.14 0 0 
episomal 0.250 2.80 0 0 
Production of expected compounds: The engineered 
yeast strains produced the expected products at a level 
of 0.1 mg/l without feeding benzoic acid in yeast strain 
INVSc1. Feeding exogenous benzoic acid increased the 
2,4,6-trihydroxybenzophenone yield by a factor of 4 
(Fig. 2). In contrast, yeast strain DD104 produced 
product only without feeding benzoic acid. Adding 
benzoic acid to a final level of 0.15 mM abolished 
product formation completely (data not shown).  
Fig. 2 Feeding benzoic acid increased the production of 
2,4,6-trihydroxybenzophenone in yeast strain INVSc1 
episomally over-expressing HpPKS006 and RpBZL and 
grown in flask cultures.  
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DISCUSSION 
Here we successfully reconstructed the benzophenone 
and xanthone biosynthetic pathway in yeast using 
constitutive promoters, which simplify the production 
procedure by eliminating the induction step. There was 
no significant difference between the episomal 
expression and the genome integration in terms of both 
growth and product formation, indicating that the 
pathways are independent of the copy number of the 
genes. A similar result has also been found in the 
production of resveratrol in engineered yeast [Li, 
2016]. The formation of benzophenone and xanthone 
proceeded by a growth-dependent manner, which has 
also been reported for resveratrol engineering works 
[Vos, 2015].  
Although there is no information about benzoic acid 
metabolism in yeast, the fact that the engineered yeasts 
produce benzophenone and xanthone without feeding 
benzoic acid indicates that endogenous benzoic acid 
exists in yeast. The engineered benzophenone and 
xanthone biosynthesis process in yeast is a de novo 
production system. Further modification of the benzoic 
pathway may be helpful for increasing the product 
yield. 
Co-expressing HpPT8 in the xanthone producing yeast 
strain failed to produce detectable amounts of 
prenylated xanthone, indicating that more optimization 
works are needed to enable the correct function of 
prenyltransferase activity in yeast, as shown previously 
by bitter acid biosynthesis in yeast [Li, 2015]. 
CONCLUSIONS 
Engineered yeast strains produce the core structures of 
PPAPs at yields of around 0.5 mg/l. This amount is 
sufficient to serve as substrate for the downstream 
prenyltransferase enzymes, which have Km values at 
approx. 200 µM. Thus, the strains so far generated can 
serve as the host strains for further reconstructing the 
complete pathways of PPAPs, which then may be 
available in sufficient quantities for the detailed 
assaying of their biological activities.  
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